Vivoo

Operating

Vivosens Inc.

Healthcare · San Francisco, CA · Founded 1905

Woman-founded

Visit website

Personal wellness advice through at-home urine sample analysis

Post-money valuation ⓘ

$7.6M

As of Sep 2020 · from Reg CF Offering (2020-08-01) · pre-money + amount raised, not a traded price

Total raised

$5,135,388

Crowd $643K · Private $4.5M · 11 rounds since 2017

Latest share price

$0.37

Reg CF · Preferred Stock · Aug 2020 offering price

Valuation over rounds

Pre-money — the valuation set before each round’s money came in

$7.5M

pre-money

Reg CF · Preferred · Aug 2020

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$1.00$0.50$0.37

Jan 2017Aug 2020

Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · Jan 2020 (-63%)

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Rule 506(b) · Equity · Sep 2021Closed

Raised $3.3MInvestors 16

Reg CF · Preferred Stock · Aug 2020Closedvia Republic

Raised $143.1K / $570KInvestors 538Post-money $7.6M

Rule 506(b) · Convertible Note · Aug 2020Closed

Raised $150KInvestors 2

Reg CF · Preferred Stock · Jan 2020Closedvia Republic

Raised $500K / $500KInvestors 1,802

Rule 506(b) · Convertible Note · Jan 2019Closed

Raised $200KInvestors 2

Rule 506(b) · SAFE · Jan 2019Closed

Raised $105KInvestors 2

Section 4(a)(2) · SAFE · Jan 2019Closed

Raised $355K

Section 4(a)(2) · SAFE · Jan 2018Closed

Raised $180K

Rule 506(b) · SAFE · Apr 2018Closed

Raised $90KInvestors 2

Private · Common Stock · Jan 2017Closed

Raised $10.1K

Rule 506(b) · Nov 2017Closed

Raised $120KInvestors 1

Team

2 people

Miray Tayfun

CEO

George Radman

CFO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 2 of 7 annual reports (FY2019–FY2025)

Missing: 2021, 2022, 2023, 2024, 2025

1,802 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 16 filings on EDGAR

Form DOct 6, 20210001793344-21-000004
EDGAR
Form C-ARJul 2, 20210001793344-21-000002
EDGAR
Form C-UOct 1, 20200001793344-20-000017
EDGAR
Form DAug 20, 20200001793344-20-000016
EDGAR
Form C/AAug 19, 20200001793344-20-000015
EDGAR
Form CJul 31, 20200001793344-20-000014
EDGAR
Form C-AR/AJul 31, 20200001793344-20-000013
EDGAR
Form C-ARMay 1, 20200001793344-20-000012
EDGAR

Source: ManualCIK 0001793344DEShare price $0.37

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.